Bright Green (Bright Green) EBIT per Share : $-0.05 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bright Green EBIT per Share?

Bright Green's EBIT per Share for the three months ended in Mar. 2024 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.05.

During the past 3 years, the average EBIT per Share Growth Rate was -38.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bright Green's EBIT per Share or its related term are showing as below:

BGXX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -38.1 Med: -38.1 Max: -38.1
Current: -38.1

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Bright Green was -38.10% per year. The lowest was -38.10% per year. And the median was -38.10% per year.

BGXX's 3-Year EBIT Growth Rate is ranked worse than
91.61% of 858 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs BGXX: -38.10

Bright Green's EBIT for the three months ended in Mar. 2024 was $-1.88 Mil.

Bright Green EBIT per Share Historical Data

The historical data trend for Bright Green's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Green EBIT per Share Chart

Bright Green Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-0.02

-0.17

-0.05

Bright Green Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial									-0.02	-0.02	-0.01	-0.01	-0.01

Bright Green EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bright Green's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.891	/	178.574
=	-0.05

Bright Green's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.878	/	187.512
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05

Bright Green (NAS:BGXX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bright Green EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bright Green's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Green (Bright Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (NAS:BGXX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1033 George Hanosh Boulevard, Grants, NM, USA, 87020

Website

https://www.brightgreen.us

Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).

Executives

Gurvinder Singh	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Saleem Elmasri	officer: Chief Financial Officer	450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Seamus Mcauley	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson	director, officer: Chief Executive Officer	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc.	10 percent owner	3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1